Exact Sciences (EXAS)
(Delayed Data from NSDQ)
$70.83 USD
+1.62 (2.34%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $70.84 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum B VGM
Balance Sheet
Fiscal Year End for Exact Sciences Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 778 | 632 | 1,030 | 1,840 | 324 |
Receivables | 204 | 158 | 217 | 233 | 131 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 127 | 118 | 105 | 92 | 62 |
Other Current Assets | 86 | 74 | 74 | 33 | 41 |
Total Current Assets | 1,194 | 982 | 1,426 | 2,199 | 557 |
Net Property & Equipment | 698 | 685 | 580 | 451 | 455 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 4,258 | 4,302 | 4,430 | 2,086 | 2,347 |
Deposits & Other Assets | 177 | 91 | 75 | 64 | 20 |
Total Assets | 6,471 | 6,227 | 6,685 | 4,925 | 3,506 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 79 | 75 | 68 | 36 | 26 |
Current Portion Long-Term Debt | 50 | 0 | 0 | 257 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 342 | 299 | 399 | 234 | 193 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 15 | 10 | 31 | 38 | 8 |
Total Current Liabilities | 515 | 413 | 517 | 576 | 236 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 2,314 | 2,186 | 2,180 | 1,321 | 804 |
Long-Term Debt | 0 | 50 | 0 | 22 | 24 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 336 | 352 | 418 | 62 | 35 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,326 | 3,184 | 3,297 | 2,102 | 1,218 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 1 |
Capital Surplus | 6,611 | 6,312 | 6,029 | 4,790 | 3,406 |
Retained Earnings | -3,469 | -3,265 | -2,642 | -1,968 | -1,120 |
Other Equity | 1 | -5 | -1 | 1 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3,145 | 3,043 | 3,388 | 2,823 | 2,288 |
Total Liabilities & Shareholder's Equity | 6,471 | 6,227 | 6,685 | 4,925 | 3,506 |
Total Common Equity | 3,145 | 3,043 | 3,388 | 2,823 | 2,288 |
Shares Outstanding | 180.80 | 177.60 | 172.30 | 150.40 | 129.80 |
Book Value Per Share | 17.40 | 17.13 | 19.66 | 18.77 | 17.63 |
Fiscal Year End for Exact Sciences Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 947 | 652 | 778 | 734 | 776 |
Receivables | 264 | 241 | 204 | 199 | 178 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 127 | 129 | 127 | 133 | 131 |
Other Current Assets | 114 | 99 | 86 | 82 | 89 |
Total Current Assets | 1,452 | 1,120 | 1,194 | 1,148 | 1,174 |
Net Property & Equipment | 703 | 702 | 698 | 692 | 687 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 4,210 | 4,234 | 4,258 | 4,280 | 4,257 |
Deposits & Other Assets | 167 | 178 | 177 | 151 | 90 |
Total Assets | 6,673 | 6,376 | 6,471 | 6,421 | 6,356 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 53 | 61 | 79 | 74 | 75 |
Current Portion Long-Term Debt | 249 | 299 | 50 | 50 | 50 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 303 | 265 | 342 | 310 | 300 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 37 | 33 | 15 | 13 | 34 |
Total Current Liabilities | 669 | 685 | 515 | 477 | 488 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 2,318 | 2,067 | 2,314 | 2,313 | 2,312 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 327 | 336 | 342 | 331 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,481 | 3,244 | 3,326 | 3,300 | 3,299 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 6,787 | 6,711 | 6,611 | 6,540 | 6,476 |
Retained Earnings | -3,595 | -3,579 | -3,469 | -3,419 | -3,420 |
Other Equity | -1 | -1 | 1 | -2 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3,192 | 3,133 | 3,145 | 3,121 | 3,057 |
Total Liabilities & Shareholder's Equity | 6,673 | 6,376 | 6,471 | 6,421 | 6,356 |
Total Common Equity | 3,192 | 3,133 | 3,145 | 3,121 | 3,057 |
Shares Outstanding | 184.70 | 183.80 | 180.80 | 180.60 | 180.40 |
Book Value Per Share | 17.28 | 17.04 | 17.40 | 17.28 | 16.94 |